Volume 5, Issue 7
Editorialp. 615–617
Data monitoring committees in clinical trials: best practice, complexities and considerations
Author(s): Simon Day
Drug Evaluationp. 621–632
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Author(s): Vincent Cottin
Drug Evaluationp. 633–641
Linaclotide for irritable bowel syndrome with constipation: a review
Author(s): Michael Arriaga & Eamonn MM Quigley
Drug Evaluationp. 643–651
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Author(s): Giovanni Barosi
Review: Clinical Trail Outcomesp. 653–664
Implementation of strategic management tools improves wound care clinical trial outcomes
Author(s): Marina Malikova, Lauren Shifflett & Alik Farber
Review: Clinical Trail Outcomesp. 665–675
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Author(s): Changhoon Yoo & Yoon-Koo Kang
